Skip to search formSkip to main contentSkip to account menu

tobanum

Known as: CLORANOLOL, chloranolol, 2-propanol, 1-(2,5-dichlorophenoxy)-3-((1,1-dimethylethyl)amino)- 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (3)

Adrenergic beta-AntagonistsAntihypertensive AgentsPropanolamines

Narrower (1)

GYKI-41099

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2001
Review
2001
[Cardiovascular system research at the Institute of Drug Research].
The most significant achievements in the cardiovascular research areas have been reviewed. Among the beta-adrenoceptor blockers… 
1991
1991
[Effectiveness and pharmacodynamics of tobanum in patients with paroxysmal reciprocal atrioventricular tachycardia].
The antiarrhythmic effects and pharmacodynamics of tobanum were evaluated in 28 patients wist paroxysms of reciprocal… 
1989
1989
Action of beta-adrenoceptor blockers on liver function of rats.
Three nonselective beta-adrenoceptor blockers, propranolol, cloranolol and talinolol, were examined in male rats. The amount and… 
1986
1986
[Clinical and cardiohemodynamic effects of the new long-acting beta-blocker tobanum].
The effects of long-acting beta-adrenoblocker tobanum on the frequency and severity of anginal attacks, bicycle ergometry… 
1985
1985
Incidence of side effects during the application of placebo and active therapy (Tobanum) in patients suffering from hypertension, angina pectoris and arrhythmia.
In a single blind clinical trial the effects of Tobanum (chloranolol), a beta-adrenergic receptor blocker, on 450 patients were… 
1984
1984
Effects of beta-adrenergic inhibitors on noradrenaline and adrenaline metabolism in brain regions of the rat.
1981
1981
Specific and sensitive method for the determination of tobanum using gas chromatography with electron-capture and mass fragmentographic detection.
1980
1980
Clinical-pharmacological evaluation of a new beta blocker, GYKI-41099 (tobanum).
The acute and chronic circulatory effects of a new beta adrenergic blocking drug, dl-1-(2,5-dichlorophenoxy)-3-tertiary… 
1980
1980
Pharmacology of GYKI-41 099 (chlorpropanol, Tobanum) a new potent beta-adrenergic antagonist.
1980
1980
Electrophysiological characteristics of tobanum, a new beta receptor blocking agent.
The electrophysiological properties of Tobanum (a new beta receptor blocking drug) were studied in 14 patients by the aid of His… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)